PTIX
Protagenic Therapeutics, Inc. - Common Stock (PTIX)
$50
About Protagenic Therapeutics, Inc. - Common Stock (PTIX)
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Details
Daily high
$0.50
Daily low
$0.50
Price at open
$0.50
52 Week High
$4.35
52 Week Low
$0.26
Market cap
965,300
Dividend yield
0.00%
Volume
2,124
Avg. volume
83,849
P/E ratio
-.07
Protagenic Therapeutics, Inc. - Common Stock News
Details
Daily high
$0.50
Daily low
$0.50
Price at open
$0.50
52 Week High
$4.35
52 Week Low
$0.26
Market cap
965,300
Dividend yield
0.00%
Volume
2,124
Avg. volume
83,849
P/E ratio
-.07